Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
about
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsOutcomes following local therapy for early-stage breast cancer in non-trial populationsAdolescent perspectives on phase I cancer researchRecruitment and retention of women for clinical leiomyoma trials.Costs of recruiting couples to a clinical trialOn cancer control and the adolescentThe Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Patient involvement in informed consent for pediatric phase I cancer research.On-line information about cancer clinical trials: evaluating the Web sites of comprehensive cancer centers.Brief report: if you build it, they will come: methods for recruiting Latinos into cancer research.Selection and description of cancer clinical trials participants--science or happenstance?Clinicians' attitudes towards clinical trials of cancer therapyA population-based assessment of specialty physician involvement in cancer clinical trials.Participation of Asian-American women in cancer chemoprevention research: physician perspectives.Challenges in recruiting Mexican women for cancer genetics research.Challenges in identifying Native Hawaiians and Pacific Islanders in population-based cancer registries in the U.S.Patterns of care for non-small-cell lung cancer at an academic institution affiliated with a national cancer institute-designated cancer center.Perceptions of Cancer Clinical Research Among African American Men in North Carolina.Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.Health Literate Organizations: Are Clinical Trial Sites Equipped to Recruit Minority and Limited Health Literacy Patients?Characterization of clinical study populations by race and ethnicity in biomedical literature.A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trialsRemoving barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.Patient income level and cancer clinical trial participation.Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumoursCancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives.A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles.Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.Participation of older patients with prostate cancer in Medicare eligible trialsComparison of survival outcomes among cancer patients treated in and out of clinical trials.The successful integration of research and care: how pediatric oncology became the subspecialty in which research defines the standard of care.Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature.Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.Launching Effectiveness Research to Guide Practice in Neurosurgery: A National Institute Neurological Disorders and Stroke Workshop Report.Clinician Perspectives on Current Issues in Lung Cancer Drug Development.A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers.Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
P2860
Q27313405-A7502875-6D93-4110-B6A5-7BAC7EEFF6E8Q28749604-9A99AD6C-BFF3-4D4D-AE79-F5F61408FEC5Q30531481-A9A16D88-1B1F-448F-9A96-10824BF4E169Q33641513-AD634DEE-517F-4FA2-B580-6E112ABBC00CQ33642501-243A889D-26C7-413D-A2D0-9FF5300BB6E7Q33652428-46A4040B-AF00-4066-AE75-5AA7B88FADBEQ33865329-8B9F2C14-D5DC-4BB0-B6F3-2BC3C51FAD14Q33976713-BFC44F92-31A7-4E03-A946-B37A829590B8Q34686428-48C650B0-7229-4B17-9578-171099CA30B7Q34723145-2EAE4718-AF5B-4009-8A53-67934D7DFA4EQ34810785-606B04F0-FF6C-4FAA-A0BB-CA8D5CC945D3Q35006767-F1EF6C7A-CAE3-40A4-B73F-53663115EB67Q35022907-287F7EBA-5A36-4369-937D-21EA70AA5FB4Q35227793-678996C0-3C6C-4E42-B39A-94A7638DDC14Q35263766-B4D45A51-413D-4938-8249-20D3F093D69EQ35315417-7350FB94-F4C0-4398-A90B-BCB7A018608DQ35695893-46762113-0FE8-4BB5-9F22-0141A2E967ACQ35771316-EB8B4A4E-A6AD-4F84-B9B6-D09A59C30485Q35788430-E80E1F7E-9726-4947-9783-B3B7962E3AD1Q35966881-21201383-39A6-4BEB-A280-317EA07C6557Q36142181-DD55FB87-A2C6-4A5B-A4D7-0DB9DE4908B2Q36251468-30CB708E-D815-4E59-B6C4-85670CB49E6BQ36517038-28B06313-22C1-44DC-8B68-2C341279ABDBQ36552760-0B6084FA-0D7A-4FE1-A9C6-74A4BFA05885Q36589626-6EF1BAC1-E261-4EBF-99FD-A7A6AB8DDE42Q36896390-E827F3E7-A630-4107-BC81-8C6BA00E45B4Q36939200-21DDE526-6E8E-4686-A2E9-EA30B7D32357Q36977562-B7A49C04-417D-412E-994B-0CE3B4583C6CQ37124478-D27B1A2A-2F5D-4790-944B-3C411818AE9CQ37191364-BBF16323-EEFF-4770-B727-03A57837EEEAQ37265086-0AAD1E62-5F43-4EF5-A667-5828361971C3Q37696455-EF08BC87-AC80-45A3-BEEE-81CBC14676A6Q37833967-0B090A2B-BC51-4D07-BE60-C1F6D6278AD0Q37984632-269298E4-FDBF-455C-98B4-F73E9117F3FEQ37990870-09F41C28-89D1-43EA-A503-8D9EE15A0F3FQ38319483-43CAE8D9-916F-42F8-B533-37B677CCFC50Q38737166-0050BD20-3875-4279-B43D-9333DAB85243Q38892840-A346CCF1-8261-445F-9B24-86B3F2D72938Q39202791-D363800B-70A7-4655-B22F-FEE26F654CE2Q39610150-329A9E9B-2FA1-4212-82A0-C290CE88B018
P2860
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Representation of African-Amer ...... itute cancer treatment trials.
@en
Representation of African-Amer ...... itute cancer treatment trials.
@nl
type
label
Representation of African-Amer ...... itute cancer treatment trials.
@en
Representation of African-Amer ...... itute cancer treatment trials.
@nl
prefLabel
Representation of African-Amer ...... itute cancer treatment trials.
@en
Representation of African-Amer ...... itute cancer treatment trials.
@nl
P2093
P356
P1476
Representation of African-Amer ...... itute cancer treatment trials.
@en
P2093
Brawley OW
Friedman MA
Trimble EL
Ungerleider RS
P304
P356
10.1093/JNCI/88.12.812
P407
P577
1996-06-01T00:00:00Z